Editorial : Scientifically unfounded precaution drives European Commission’s recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles

Dietrich, Daniel R and von Aulock, Sonja and Marquardt, Hans and Blaauboer, Bas and Dekant, Wolfgang and Hengstler, Jan and Collier, Abby and Gori, Gio Batta and Pelkonen, Olavi and Lang, Florian and Nijkamp, Frans P and Stemmer, Kerstin and Li, Albert and Savolainen, Kai and Hayes, A Wallace and Gooderham, Nigel and Harvey, Alan (2013) Editorial : Scientifically unfounded precaution drives European Commission’s recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles. Regulatory Toxicology and Pharmacology, 67 (3). pp. 317-320. (https://doi.org/10.1016/j.yrtph.2013.07.001)

Abstract

We, the undersigned editors of prominent journals of pharmacology and toxicology, are drawing your attention to the imminent decisions by the European Commission to enforce a regulatory framework for so-called endocrine disrupting chemicals (EDCs). The currently drafted framework is based on virtually complete ignorance of all well-established and taught principles of pharmacology and toxicology, of opinions raised by the European Commission’s own competent expert authority (European Food Safety Authority (EFSA, 2013), and of critical statements made by member countries, while avoiding asking for support from the European Commission’s own scientific expert committees.

• Share and Export
  

  RDF+XMLBibTeXRIOXX2 XMLRDF+N-TriplesJSONDublin CoreAtomSimple MetadataReferMETSHTML CitationASCII CitationOpenURL ContextObjectEndNoteOpenURL ContextObject in SpanMODSMPEG-21 DIDLEP3 XMLData Cite XMLRIS (EndNote Online, Zotero, Ref manager, etc)RDF+N3Multiline CSV
• Item metadata

  Item type:	Article
  ID code:	47965
  Dates:	Date Event December 2013 Published
  Notes:	The text was prepared in response to the present discussion regarding the European Commission’s recommendations on the so-called “endocrine disrupting chemicals” and is supported by the Editor of Regulatory Toxicology and Pharmacology. It also refers to a letter sent in response to these recommendations and that was undersigned by a group of toxicologists. This or a similar editorial will appear in other toxicology and pharmacology journals.
  Subjects:	Medicine > Therapeutics. Pharmacology
  Department:	Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
  Depositing user:	Pure Administrator
  Date deposited:	09 May 2014 11:06
  Last modified:	11 Nov 2024 10:41
  URI:	https://strathprints.strath.ac.uk/id/eprint/47965